Study Indicates That ChromeMate® Favorably Influences Genes That Promote Muscle Development, Burning of Brown Fat

Study Indicates That ChromeMate® Favorably Influences Genes That Promote Muscle Development, Burning of Brown Fat Results of a new mouse study, published in Physiology Genomics, indicate that ChromeMate positively influenced the expression of numerous genes involved in fat metabolism and muscle development.
Home Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P. Natrol Appoints Vincent Andrich VP Sales for Prolab Division Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results Body Shop Reports 24.8 Mil Euro Sales Revenues Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label Supplement Group Targets Consumer Education Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO drugstore.com Expects to Reach Profitability Target in 2003 Human Genome Project Leads to Innovative Healthcare NPIcenter’s Career Center targets nutraceutical Industry Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders Editorial: An Exercise in Synergy NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway Natural Health Trends Corp. Launches Lexxus Taiwan FDA Presents Compliance Guide for Structure/Function Claims New TrimFit® Bars Redefine Energy Bar Category New TrimFit® Bars Redefine Energy Bar Category Probiata® Offers Safe, Natural and Effective Alternative Alive & Well with Michelle Harris Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com Consumers Search for Healthy Cleaning Products That Work Nordic Naturals: Omega 3 Fatty Acids Cyanotech Names Bob Capelli as Director of Sales Daily Supplement May Boost Birthweight of Babies In The Developing World Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies. Daily Supplement May Boost Birthweight of Babies In The Developing World Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies. Daily Supplement May Boost Birthweight of Babies In The Developing World Giving pregnant women in the developing world a daily supplement containing 10 vitamins and five minerals could help increase the birthweight of their babies. Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects. Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects. Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects. Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects. Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects. Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects. Minnesota Applied Research Center Completes 1000 Subject Visits in Weight Loss Trials and adds DXA Scanning Capabilities MARC announces the completion of more than 1000 subject visits in weight loss trials at the clinical research center this summer, as well as new technical capabilities in the form of three PASSPORT Monitors, two new TRUE ONE® 2400 Metabolic Measurement Systems, and a new state-of-the-art Lunar Prodigy Advance Plus Dual Energy X-Ray Absorptiometry (DXA) machine. Minnesota Applied Research Center Completes 1000 Subject Visits in Weight Loss Trials and adds DXA Scanning Capabilities MARC announces the completion of more than 1000 subject visits in weight loss trials at the clinical research center this summer, as well as new technical capabilities in the form of three PASSPORT Monitors, two new TRUE ONE® 2400 Metabolic Measurement Systems, and a new state-of-the-art Lunar Prodigy Advance Plus Dual Energy X-Ray Absorptiometry (DXA) machine. Minnesota Applied Research Center Completes 1000 Subject Visits in Weight Loss Trials and adds DXA Scanning Capabilities MARC announces the completion of more than 1000 subject visits in weight loss trials at the clinical research center this summer, as well as new technical capabilities in the form of three PASSPORT Monitors, two new TRUE ONE® 2400 Metabolic Measurement Systems, and a new state-of-the-art Lunar Prodigy Advance Plus Dual Energy X-Ray Absorptiometry (DXA) machine. Minnesota Applied Research Center Completes 1000 Subject Visits in Weight Loss Trials and adds DXA Scanning Capabilities MARC announces the completion of more than 1000 subject visits in weight loss trials at the clinical research center this summer, as well as new technical capabilities in the form of three PASSPORT Monitors, two new TRUE ONE® 2400 Metabolic Measurement Systems, and a new state-of-the-art Lunar Prodigy Advance Plus Dual Energy X-Ray Absorptiometry (DXA) machine. Minnesota Applied Research Center Completes 1000 Subject Visits in Weight Loss Trials and adds DXA Scanning Capabilities MARC announces the completion of more than 1000 subject visits in weight loss trials at the clinical research center this summer, as well as new technical capabilities in the form of three PASSPORT Monitors, two new TRUE ONE® 2400 Metabolic Measurement Systems, and a new state-of-the-art Lunar Prodigy Advance Plus Dual Energy X-Ray Absorptiometry (DXA) machine. New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight. New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight. New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight. New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight. New Published Study on Relora® Reveals Safe and Effective Help for the Stress-Weight Connection Randomized, double-blind placebo-controlled clinical trial was conducted to determine the efficacy of Relora in helping overweight, otherwise healthy, premenopausal female adults, who typically eat more in stressful situations manage their body weight. PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes. PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes. PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes. PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes. PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes. PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes. PacificHealth Laboratories Awards Research Grant to Manchester University; Grant Will Expand Research Efforts in Weight Loss and Type II Diabetes Company has awarded a research grant to the Gastrointestinal Sciences Research Group at The University of Manchester, Manchester, England to expand its research and product development program in weight loss and Type II diabetes. New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process. New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process. New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process. New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process. New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process. New Study: CLA May Serve Critical Role in Preventing Weight and Fat Gain During Year-End Holidays and with Normal Aging A new study published online in the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits by preventing weight and fat gain commonly experienced by adults during the November-December holiday season, and in the normal aging process. New Research Shows Natural Resistant Starch Increases Metabolic Biomarkers for Satiety and Reduces Abdominal Fat New research presented at the 2006 Annual Meeting of NAASO, The Obesity Society, yesterday showed that fermentation of natural resistant starch derived from corn is an important and previously under-estimated mechanism in weight management with more impact on cellular metabolism and fat deposition than the other mechanisms of dietary fiber. New Research Shows Natural Resistant Starch Increases Metabolic Biomarkers for Satiety and Reduces Abdominal Fat New research presented at the 2006 Annual Meeting of NAASO, The Obesity Society, yesterday showed that fermentation of natural resistant starch derived from corn is an important and previously under-estimated mechanism in weight management with more impact on cellular metabolism and fat deposition than the other mechanisms of dietary fiber. New Research Shows Natural Resistant Starch Increases Metabolic Biomarkers for Satiety and Reduces Abdominal Fat New research presented at the 2006 Annual Meeting of NAASO, The Obesity Society, yesterday showed that fermentation of natural resistant starch derived from corn is an important and previously under-estimated mechanism in weight management with more impact on cellular metabolism and fat deposition than the other mechanisms of dietary fiber. Weight Loss Activity of Svetol® Demonstrated in New Clinical Study Company announces that a recent study published in Phytothérapie reveals the ability of Svetol®, Berkem’s unique extract of decaffeinated green coffee beans, to reduce body mass index (BMI) and to increase the lean mass to fat mass ratio. Weight Loss Activity of Svetol® Demonstrated in New Clinical Study Company announces that a recent study published in Phytothérapie reveals the ability of Svetol®, Berkem’s unique extract of decaffeinated green coffee beans, to reduce body mass index (BMI) and to increase the lean mass to fat mass ratio. Weight Loss Activity of Svetol® Demonstrated in New Clinical Study Company announces that a recent study published in Phytothérapie reveals the ability of Svetol®, Berkem’s unique extract of decaffeinated green coffee beans, to reduce body mass index (BMI) and to increase the lean mass to fat mass ratio. Pilot Study Shows Cevena’s Viscofiber®, Combined with Diet And Lifestyle Program, Promotes Significant Weight Loss Company has completed a pilot study of its flagship ingredient Viscofiber® demonstrating that the combination of Viscofiber®, a calorie-restricted diet and healthy lifestyle caused a significant loss of weight. Pilot Study Shows Cevena’s Viscofiber®, Combined with Diet And Lifestyle Program, Promotes Significant Weight Loss Company has completed a pilot study of its flagship ingredient Viscofiber® demonstrating that the combination of Viscofiber®, a calorie-restricted diet and healthy lifestyle caused a significant loss of weight. Pilot Study Shows Cevena’s Viscofiber®, Combined with Diet And Lifestyle Program, Promotes Significant Weight Loss Company has completed a pilot study of its flagship ingredient Viscofiber® demonstrating that the combination of Viscofiber®, a calorie-restricted diet and healthy lifestyle caused a significant loss of weight. Tonalin® CLA may serve critical role in preventing weight and fat gain A study published in the March 2007 issue of the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits in preventing weight and fat gain commonly experienced by adults as part of the normal aging process. Tonalin® CLA may serve critical role in preventing weight and fat gain A study published in the March 2007 issue of the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits in preventing weight and fat gain commonly experienced by adults as part of the normal aging process. Tonalin® CLA may serve critical role in preventing weight and fat gain A study published in the March 2007 issue of the International Journal of Obesity suggests that Tonalin® CLA could have long-term health benefits in preventing weight and fat gain commonly experienced by adults as part of the normal aging process. New Clinical Study on Clarinol(TM) CLA Confirms Regional-Specific Fat Mass Decrease in Overweight and Obese Study published in the British Journal of Nutrition suggest that Clarinol(TM) CLA reduces fat mass in particular locations on the body (in the leg and waist areas for women and in the waist area/mid-section for men), after three months, without any additional exercise. New Clinical Study on Clarinol(TM) CLA Confirms Regional-Specific Fat Mass Decrease in Overweight and Obese Study published in the British Journal of Nutrition suggest that Clarinol(TM) CLA reduces fat mass in particular locations on the body (in the leg and waist areas for women and in the waist area/mid-section for men), after three months, without any additional exercise. New Clinical Study on Clarinol(TM) CLA Confirms Regional-Specific Fat Mass Decrease in Overweight and Obese Study published in the British Journal of Nutrition suggest that Clarinol(TM) CLA reduces fat mass in particular locations on the body (in the leg and waist areas for women and in the waist area/mid-section for men), after three months, without any additional exercise. Calcium, Vitamin D Supplements May Help Prevent Weight Gain in Postmenopausal Women A report featured in the May 14, 2007 edition of Archives of Internal Medicine evaluated 36,282 postmenopausal women ages 50 to 79 years who were enrolled in the Women's Health Initiative clinical trial, observing that those who took daily calcium and vitamin D supplements over a seven-year period weighed an average 0.28 pounds less, and were less likely to gain weight than women who received placebos. Calcium, Vitamin D Supplements May Help Prevent Weight Gain in Postmenopausal Women A report featured in the May 14, 2007 edition of Archives of Internal Medicine evaluated 36,282 postmenopausal women ages 50 to 79 years who were enrolled in the Women's Health Initiative clinical trial, observing that those who took daily calcium and vitamin D supplements over a seven-year period weighed an average 0.28 pounds less, and were less likely to gain weight than women who received placebos. Calcium, Vitamin D Supplements May Help Prevent Weight Gain in Postmenopausal Women A report featured in the May 14, 2007 edition of Archives of Internal Medicine evaluated 36,282 postmenopausal women ages 50 to 79 years who were enrolled in the Women's Health Initiative clinical trial, observing that those who took daily calcium and vitamin D supplements over a seven-year period weighed an average 0.28 pounds less, and were less likely to gain weight than women who received placebos. Calcium, Vitamin D Supplements May Help Prevent Weight Gain in Postmenopausal Women A report featured in the May 14, 2007 edition of Archives of Internal Medicine evaluated 36,282 postmenopausal women ages 50 to 79 years who were enrolled in the Women's Health Initiative clinical trial, observing that those who took daily calcium and vitamin D supplements over a seven-year period weighed an average 0.28 pounds less, and were less likely to gain weight than women who received placebos. Calcium, Vitamin D Supplements May Help Prevent Weight Gain in Postmenopausal Women A report featured in the May 14, 2007 edition of Archives of Internal Medicine evaluated 36,282 postmenopausal women ages 50 to 79 years who were enrolled in the Women's Health Initiative clinical trial, observing that those who took daily calcium and vitamin D supplements over a seven-year period weighed an average 0.28 pounds less, and were less likely to gain weight than women who received placebos. Calcium, Vitamin D Supplements May Help Prevent Weight Gain in Postmenopausal Women A report featured in the May 14, 2007 edition of Archives of Internal Medicine evaluated 36,282 postmenopausal women ages 50 to 79 years who were enrolled in the Women's Health Initiative clinical trial, observing that those who took daily calcium and vitamin D supplements over a seven-year period weighed an average 0.28 pounds less, and were less likely to gain weight than women who received placebos. Meta-analysis: Tonalin® CLA May Help Reduce Fat Mass and Offer Long-Term Health Benefits – Especially for Yo-Yo Dieters A new meta-analysis of human studies on the efficacy of conjugated linoleic acid (CLA) and body composition, published in the American Journal of Clinical Nutrition1, examined 18 clinical trials (of which 15 used Tonalin® CLA), determining that CLA could enhance overall health by effectively reducing body fat, and potentially preventing weight and fat regain commonly experienced by adults, especially yo-yo dieters. Meta-analysis: Tonalin® CLA May Help Reduce Fat Mass and Offer Long-Term Health Benefits – Especially for Yo-Yo Dieters A new meta-analysis of human studies on the efficacy of conjugated linoleic acid (CLA) and body composition, published in the American Journal of Clinical Nutrition1, examined 18 clinical trials (of which 15 used Tonalin® CLA), determining that CLA could enhance overall health by effectively reducing body fat, and potentially preventing weight and fat regain commonly experienced by adults, especially yo-yo dieters. Meta-analysis: Tonalin® CLA May Help Reduce Fat Mass and Offer Long-Term Health Benefits – Especially for Yo-Yo Dieters A new meta-analysis of human studies on the efficacy of conjugated linoleic acid (CLA) and body composition, published in the American Journal of Clinical Nutrition1, examined 18 clinical trials (of which 15 used Tonalin® CLA), determining that CLA could enhance overall health by effectively reducing body fat, and potentially preventing weight and fat regain commonly experienced by adults, especially yo-yo dieters. Second Prolibra® Study Shows Improved Body Composition by Targeting Fat Loss A new report, based on a 12-week double-blind, placebo-controlled study, indciates that Prolibra has a significant impact on fat loss and muscle mass retention. Second Prolibra® Study Shows Improved Body Composition by Targeting Fat Loss A new report, based on a 12-week double-blind, placebo-controlled study, indciates that Prolibra has a significant impact on fat loss and muscle mass retention. Second Prolibra® Study Shows Improved Body Composition by Targeting Fat Loss A new report, based on a 12-week double-blind, placebo-controlled study, indciates that Prolibra has a significant impact on fat loss and muscle mass retention. In Vitro Study Reveals Potential Weight Loss Effects of Mangosteen Juice Supplement Mango-xan The results of a recent in-vitro study (to be presented at the American Chemical Society's 62nd Annual Northwest Regional Meeting being held June 17 - 20, 2007 in Boise, Idaho) show that compounds in Mango-xan, a mangosteen juice supplement from Pure Fruit Technologies, bound with B-1 and B-3 adrenergic receptor cells. This binding significantly stimulated the production of enzymes linked to increasing energy and fat metabolism. In Vitro Study Reveals Potential Weight Loss Effects of Mangosteen Juice Supplement Mango-xan The results of a recent in-vitro study (to be presented at the American Chemical Society's 62nd Annual Northwest Regional Meeting being held June 17 - 20, 2007 in Boise, Idaho) show that compounds in Mango-xan, a mangosteen juice supplement from Pure Fruit Technologies, bound with B-1 and B-3 adrenergic receptor cells. This binding significantly stimulated the production of enzymes linked to increasing energy and fat metabolism. In Vitro Study Reveals Potential Weight Loss Effects of Mangosteen Juice Supplement Mango-xan The results of a recent in-vitro study (to be presented at the American Chemical Society's 62nd Annual Northwest Regional Meeting being held June 17 - 20, 2007 in Boise, Idaho) show that compounds in Mango-xan, a mangosteen juice supplement from Pure Fruit Technologies, bound with B-1 and B-3 adrenergic receptor cells. This binding significantly stimulated the production of enzymes linked to increasing energy and fat metabolism. Fabuless™ Weight Management from DSM Fabuless™ Weight Management from DSM Fabuless™ Weight Management from DSM Fabuless™ Weight Management from DSM Fabuless™ Weight Management from DSM Sweet music for Fabuless Sweet music for Fabuless Sweet music for Fabuless Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Synergy Flavors Invests in Sensory Flavor Profiling Research Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders. NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Heart Health Alert: Niacin May Reverse Hardening of the Arteries Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Spotlight on Savory Side Dishes Another Reason to Choose Healthy Lifestyle Habits Another Reason to Choose Healthy Lifestyle Habits	BENICIA, Calif., January 16, 2007 – In a promising new study, researchers at Ohio State University Medical Center have shown that ChromeMate® affects fat metabolism and muscle activity at the genetic level. ChromeMate, produced by InterHealth Nutraceuticals, is an oxygen-coordinated niacin-bound form of supplemental chromium that has previously been shown to promote healthy glucose metabolism and lipid profiles, as well as lean body mass. It has been affirmed GRAS (Generally Recognized as Safe) for use in functional beverages. In this new study, researchers looked at the effect that ChromeMate might have on risk factors involved in Metabolic Syndrome, a cluster of symptoms that can include abdominal obesity, inefficient insulin action, high triglyceride and LDL (“bad”) cholesterol levels, and low levels of HDL (“good”) cholesterol. Metabolic Syndrome can increase the risk of developing cardiovascular disease and type-2 diabetes. The results of the new study showed that ChromeMate positively influenced the expression of numerous genes involved in fat metabolism and muscle development. The study, recently published in Physiology Genomics, was conducted with Leprdb mice, which are born obese and diabetic and are a useful model for studying Metabolic Syndrome. The Leprdb mice typically suffer from abnormally high blood glucose and lipid profiles beginning at 30 days of life. Researchers investigated the effects of ChromeMate versus placebo on the subcutaneous fat tissue (the fat tissue that lies under the second layer of the skin) of the animals by means of Gene Microarray Analysis, using more than 45,000 sets of mouse genome. ChromeMate up-regulated (activated) the expression of four muscle-specific genes within the subcutaneous fat. These genes provide the signal for pre-adipocytes (fat precursor cells) to produce muscle instead of fat cells. These findings corroborate earlier studies showing that ChromeMate enhances the production of lean body mass. ChromeMate down-regulated (de-activated) genes that encode (possess genetic information) for CIDEA and UCP1, which are key components in brown fat tissue thermogenesis, or the burning of fat for heat production. CIDEA is considered a “candidate” gene for obesity; mice that do not possess this gene are resistant to diet-induced obesity and diabetes. ChromeMate also down-regulated TTP, a gene that provides antioxidant support to all tissues for survival, in the subcutaneous fat. Therefore, ChromeMate stops antioxidant support to the subcutaneous fat tissues and ultimately kills the fat cells. “We were very pleased with these findings,” said Debasis Bagchi, Ph.D., F.A.C.N., Senior Vice President of Research and Development for InterHealth. “The down-regulation of CIDEA and UCP1 is particularly heartening, because of their specific role related to obesity and because brown fat is the most difficult type of fat for people to lose. These results tell us that supplementation may in fact help individuals who are predisposed to having a problem losing brown fat tissue,” Dr. Bagchi added. Dr. Bagchi also pointed out that ChromeMate influenced only a small select percentage of the genes screened, signifying that the supplement’s effect was limited to genes that it could positively impact and did not affect genes that could alter normal body functions or be considered indicators of toxicity in the body. Prior to conducting the gene expression tests, researchers investigated the effects of ChromeMate supplementation versus placebo on blood lipid and glucose profiles in the Leprdb mice. The findings corroborated previous studies showing that ChromeMate improved blood lipids and increased the clearance of glucose from the bloodstream. ChromeMate significantly lowered total cholesterol, LDL cholesterol and triglyceride levels, and increased the level of HDL cholesterol. In addition, blood glucose cleared more rapidly in response to an oral glucose tolerance test. # # # About InterHealth Nutraceuticals, Inc. InterHealth Nutraceuticals researches, develops, markets and distributes specialty nutritional ingredients, which are sold worldwide to manufacturers of dietary supplements and nutraceutical food and beverage products. The company’s products include Super CitriMax®, ChromeMate®, Aller-7®, OptiBerry ®, UC-II®, L-OptiZinc®, Protykin® and ZMA®. For more information about InterHealth and its products, call 1-800-783-4636 or 1-707-751-2800 (outside U.S.) or visit the website at www.interhealthusa.com.
Powered By Traffic Booster Absolute News Manager Plug-in by Xigla Software